SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
0.28
%
2,95%
Latest
9.78
High
9.82
Low
9.58
Volume
10 671
Turnover (SEK)
103 822
Value (MSEK)
170,8

Board

CEO

  • Ann Gidner

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 45,84 73,33 2021-06-30
Rolf Karlsson 6,42 3,16 2021-09-30
Avanza Pension 4,10 2,02 2021-09-30
Jan Zetterberg 3,24 1,60 2021-09-30
Ernst Carl Fredrik Herslow 3,20 1,58 2021-09-30
Helena Lomberg 1,49 0,74 2021-09-30
Nordnet Pensionsförsäkring 1,43 0,70 2021-09-30
Swedbank Försäkring 1,38 0,68 2021-09-30
Monica Strömberg 1,11 0,55 2021-09-30
Daniel Åberg 0,86 0,42 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2021-11-18 Delårsrapport 2022-Q1

  • 2021-11-24 Årsstämma 2021